Boan Biotech has raised 682 million yuan ($106 million) from a host of investors including YuanBio Venture Capital. In a separate development, Qinbaobao has secured its Series D funding of 250 million yuan ($39 million) from Fortune Capital and Shenzhen Capital.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
